Chart, Cash and Scenarios, page-18

It is highly unclear why a partner might now be found for oxymorphone.


As I mentioned post AGM, here is a classic example of uninformed naysayer rhetoric that is baseless and blatantly designed to inflame.

Why Southoz?

Because you obviously have not taken 1 sec of your time to speak to anyone regarding the current situation. You choose to ignore posts that highlight those specific conversations and statements made by the company at the AGM (which I am sure you did not attend) and you add blatant mis-information as Jevalent.

If you truly can't see a reason why a partner may be found after trial results showed phase II equivalence for efficacy of a world first oxymorphone patch, then you need to reconsider your analytic capabilities.